Does reperfusion injury exist in humans?
RA Kloner
Heart Institute, Hospital of the Good Samaritan, Los Angeles, California 90017-2395.
Timely coronary reperfusion as treatment for acute myocardial infarction reduces myocardial infarct size, improves left ventricular function and survival. There is still concern that at the time of reperfusion, a further injury occurs to the myocardium. Theoretically, if this "reperfusion injury" could be treated and eliminated, the outcome for patients with myocardial infarction might further improve. The concept of reperfusion injury is closely tied to the concept that oxygen radicals generated at the time of reperfusion cause tissue damage. There are four basic forms of reperfusion injury. Lethal reperfusion injury is described as myocyte cell death due to reperfusion itself rather than to the preceding ischemia. This concept continues to be controversial in both experimental animal and clinical studies. Vascular reperfusion injury refers to progressive damage to the vasculature over time during the phase of reperfusion. Manifestations of vascular reperfusion injury include an expanding zone of no reflow and a deterioration of coronary flow reserve. This form of reperfusion injury has been documented in animal models and probably occurs in humans. Stunned myocardium refers to postischemic ventricular dysfunction of viable myocytes and probably represents a form of "functional reperfusion injury." This phenomenon is well documented in both animal models and humans. Reperfusion arrhythmias represent the fourth form of reperfusion injury. They include ventricular tachycardia and fibrillation that occur within seconds to minutes of restoration of coronary flow after brief (5 to 15 min) episodes of myocardial ischemia. True reperfusion arrhythmias occur in only a small percentage of patients receiving thrombolytic therapy for acute myocardial infarction and are not a sensitive indicator for successful reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
R. S. Schwartz, A. Burke, A. Farb, D. Kaye, J. R. Lesser, T. D. Henry, and R. Virmani
Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death: Relation to Epicardial Plaque Histopathology
J. Am. Coll. Cardiol.,
December 1, 2009;
54(23):
2167 - 2173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gomez, B. Li, N. Mewton, I. Sanchez, C. Piot, M. Elbaz, and M. Ovize
Inhibition of mitochondrial permeability transition pore opening: translation to patients
Cardiovasc Res,
July 15, 2009;
83(2):
226 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Beyersdorf
The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage
Cardiovasc Res,
July 15, 2009;
83(2):
262 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Timmers, J. P.S. Henriques, D. P.V. de Kleijn, J. H. DeVries, H. Kemperman, P. Steendijk, C. W.J. Verlaan, M. Kerver, J. J. Piek, P. A. Doevendans, et al.
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury.
J. Am. Coll. Cardiol.,
February 10, 2009;
53(6):
501 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T. T. Cung, E. Bonnefoy, D. Angoulvant, et al.
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
N. Engl. J. Med.,
July 31, 2008;
359(5):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T. T. Cung, E. Bonnefoy, D. Angoulvant, J.-F. Aupetit, et al.
Long-Term Benefit of Postconditioning
Circulation,
February 26, 2008;
117(8):
1037 - 1044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Heper, M. E. Korkmaz, and A. Kilic
Reperfusion Arrhythmias: Are They Only a Marker of Epicardial Reperfusion or Continuing Myocardial Ischemia After Acute Myocardial Infarction?
Angiology,
January 1, 2008;
58(6):
663 - 670.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Yellon and D. J. Hausenloy
Myocardial Reperfusion Injury
N. Engl. J. Med.,
September 13, 2007;
357(11):
1121 - 1135.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
Cardiovasc Res,
June 1, 2007;
74(3):
343 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kasama, T. Toyama, T. Hatori, H. Sumino, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction
J. Am. Coll. Cardiol.,
February 13, 2007;
49(6):
667 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Dijkmans, R. Senior, H. Becher, T. R. Porter, K. Wei, C. A. Visser, and O. Kamp
Myocardial Contrast Echocardiography Evolving as a Clinically Feasible Technique for Accurate, Rapid, and Safe Assessment of Myocardial Perfusion: The Evidence So Far
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2168 - 2177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. W. Bar, D. Tzivoni, M. T. Dirksen, A. Fernandez-Ortiz, G. R. Heyndrickx, J. Brachmann, J. H.C. Reiber, N. Avasthy, J. Tatsuno, M. Davies, et al.
Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study
Eur. Heart J.,
November 1, 2006;
27(21):
2516 - 2523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Basso and G Thiene
The pathophysiology of myocardial reperfusion: a pathologist's perspective
Heart,
November 1, 2006;
92(11):
1559 - 1562.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Maurer
Adenosine as an adjunct to reperfusion in myocardial infarction
Eur. Heart J.,
October 2, 2006;
27(20):
2376 - 2377.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Gateau-Roesch, L. Argaud, and M. Ovize
Mitochondrial permeability transition pore and postconditioning
Cardiovasc Res,
May 1, 2006;
70(2):
264 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Staat, G. Rioufol, C. Piot, Y. Cottin, T. T. Cung, I. L'Huillier, J.-F. Aupetit, E. Bonnefoy, G. Finet, X. Andre-Fouet, et al.
Postconditioning the Human Heart
Circulation,
October 4, 2005;
112(14):
2143 - 2148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Krombach, C. B. Higgins, M. Chujo, and M. Saeed
Gadomer-enhanced MR Imaging in the Detection of Microvascular Obstruction: Alleviation with Nicorandil Therapy
Radiology,
August 1, 2005;
236(2):
510 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tomoda and N. Aoki
Right Bundle Branch Block in Acute Myocardial Infarction Treated by Primary Coronary Angioplasty and Stenting
Angiology,
March 1, 2005;
56(2):
131 - 136.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takada, M. Hashimoto, J. Kasahara, K. Aihara, and K. Fukunaga
Cytoprotective Effect of Sodium Orthovanadate on Ischemia/Reperfusion-Induced Injury in the Rat Heart Involves Akt Activation and Inhibition of Fodrin Breakdown and Apoptosis
J. Pharmacol. Exp. Ther.,
December 1, 2004;
311(3):
1249 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Johnson, L. Schofield, M. Bouchard, L. Chaves, A. Poppas, S. Reinert, P. Zalesky, J. Creech, and D. O. Williams
Hyperbaric oxygen solution infused into the anterior interventricular vein at reperfusion reduces infarct size in swine
Am J Physiol Heart Circ Physiol,
November 1, 2004;
287(5):
H2234 - H2240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T Dirksen, G. Laarman, A. W.J van 't Hof, G. Guagliumi, W. A.L Tonino, L. Tavazzi, D. J.G.M Duncker, M. L Simoons, and on behalf of the PARI-MI Investigators
The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty: Safety and efficacy of a novel tetrapeptide, ITF-1697
Eur. Heart J.,
March 1, 2004;
25(5):
392 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Palatianos, G. Balentine, E. G. Papadakis, C. D. Triantafillou, M. I. Vassili, A. Lidoriki, A. Dinopoulos, and G. M. Astras
Neutrophil depletion reduces myocardial reperfusion morbidity
Ann. Thorac. Surg.,
March 1, 2004;
77(3):
956 - 961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J Hausenloy and D. M Yellon
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
Cardiovasc Res,
February 15, 2004;
61(3):
448 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaul and H. Ito
Microvasculature in Acute Myocardial Ischemia: Part II: Evolving Concepts in Pathophysiology, Diagnosis, and Treatment
Circulation,
January 27, 2004;
109(3):
310 - 315.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J Hausenloy, M. R Duchen, and D. M Yellon
Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury
Cardiovasc Res,
December 1, 2003;
60(3):
617 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Vetterlein, C. Schrader, R. Volkmann, M. Neckel, M. Ochs, G. Schmidt, and G. Hellige
Extent of damage in ischemic, nonreperfused, and reperfused myocardium of anesthetized rats
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H755 - H765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y Nohtomi, M Takeuchi, K Nagasawa, K Arimura, K Miyata, K Kuwata, T Yamawaki, S Kondo, A Yamada, and S Okamatsu
Persistence of systolic coronary flow reversal predicts irreversible dysfunction after reperfused anterior myocardial infarction
Heart,
April 1, 2003;
89(4):
382 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Bell and D. M. Yellon
Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway
J. Am. Coll. Cardiol.,
February 5, 2003;
41(3):
508 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Goswami, J. M. Moody Jr, and S. R. Bailey
Percutaneous Mechanical Reperfusion During Acute Myocardial Infarction
J Intensive Care Med,
July 1, 2002;
17(4):
162 - 173.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Avkiran and M. S. Marber
Na+/h+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects
J. Am. Coll. Cardiol.,
March 6, 2002;
39(5):
747 - 753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Rezkalla and R. A. Kloner
No-Reflow Phenomenon
Circulation,
February 5, 2002;
105(5):
656 - 662.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Zeymer, H. Suryapranata, J. P. Monassier, G. Opolski, J. Davies, G. Rasmanis, G. Linssen, U. Tebbe, R. Schroder, R. Tiemann, et al.
The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1644 - 1650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Eeckhout and M.J Kern
The coronary no-reflow phenomenon: a review of mechanisms and therapies
Eur. Heart J.,
May 1, 2001;
22(9):
729 - 739.
[PDF]
|
 |
|

|
 |

|
 |
 
U Zeymer, R Schroder, U Tebbe, G.P Molhoek, K Wegscheider, and K.-L Neuhaus
Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction. Results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial
Eur. Heart J.,
May 1, 2001;
22(9):
769 - 775.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Xing and J. B. Martins
Myocardial ischemia-reperfusion damage impacts occurrence of ventricular fibrillation in dogs
Am J Physiol Heart Circ Physiol,
February 1, 2001;
280(2):
H684 - H692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Roe, E. M. Ohman, A. C. P. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff
Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
9 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B Patel, K. S Kilgore, G. A Ortolano, C. L Gryboski, M. A Qureshi, P. Marcovitz, K. B Naylor, J. L Park, B. Wenz, N. Gikakis, et al.
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction
Perfusion,
January 1, 2001;
16(1_suppl):
39 - 49.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Feldman, D. Himbert, J.-M. Juliard, G. J. Karrillon, H. Benamer, P. Aubry, O. Boudvillain, P. Seknadji, M. Faraggi, and P. G. Steg
Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size
J. Am. Coll. Cardiol.,
April 1, 2000;
35(5):
1162 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Karila-Cohen, D Czitrom, E Brochet, M Faraggi, P Seknadji, D Himbert, J.-M Juliard, P Assayag, and P.G Steg
Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina
Eur. Heart J.,
December 1, 1999;
20(23):
1724 - 1730.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Mahaffey, J. A. Puma, N. A. Barbagelata, M. F. DiCarli, M. A. Leesar, K. F. Browne, P. R. Eisenberg, R. Bolli, A. C. Casas, V. Molina-Viamonte, et al.
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial
J. Am. Coll. Cardiol.,
November 15, 1999;
34(6):
1711 - 1720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Gibson, K. A. Ryan, S. A. Murphy, R. Mesley, S. J. Marble, R. P. Giugliano, C. P. Cannon, E. M. Antman, E. Braunwald, and for the TIMI Study Group
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction
J. Am. Coll. Cardiol.,
October 1, 1999;
34(4):
974 - 982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shibata, K. Ueshima, M. Harada, M. Nakamura, K. Hiramori, S. Endo, N. Sato, H. Mukaida, T. Suzuki, T. Suzuki, et al.
Effect of Magnesium Sulfate Pretreatment and Significance of Matrix Metalloproteinase-1 and Interleukin-6 Levels in Coronary Reperfusion Therapy for Patients with Acute Myocardial Infarction
Angiology,
July 1, 1999;
50(7):
573 - 582.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Matetzky, D. Freimark, P. Chouraqui, I. Novikov, O. Agranat, B. Rabinowitz, E. Kaplinsky, and H. Hod
The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion
J. Am. Coll. Cardiol.,
November 1, 1998;
32(5):
1326 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakuma, Y. Hayashi, K. Sumii, M. Imazu, and M. Yamakido
Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization
J. Am. Coll. Cardiol.,
October 1, 1998;
32(4):
890 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kondo, A. Nakano, D. Saito, and Y. Shimono
Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction
J. Am. Coll. Cardiol.,
October 1, 1998;
32(4):
898 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Smits, M. McVey, B. F. Cox, M. H. Perrone, and K. L. Clark
Cardioprotective Effects of the Novel Adenosine A1/A2 Receptor Agonist AMP 579 in a Porcine Model of Myocardial Infarction
J. Pharmacol. Exp. Ther.,
August 1, 1998;
286(2):
611 - 618.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H.M. Piper, D. Garcna-Dorado, and M. Ovize
A fresh look at reperfusion injury
Cardiovasc Res,
May 1, 1998;
38(2):
291 - 300.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Murrah, E. R. Ferguson, R. D. Spruell, and W. L. Holman
Arrest Duration Influences Postcardioplegia Electrophysiologic Recovery and Reperfusion Arrhythmias
Ann. Thorac. Surg.,
April 1, 1998;
65(4):
1003 - 1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Delanty, M.P. Reilly, D. Pratico, J.A. Lawson, J.F. McCarthy, A.E. Wood, S.T. Ohnishi, D.J. Fitzgerald, and G.A. FitzGerald
8-Epi PGF2{alpha} Generation During Coronary Reperfusion: A Potential Quantitative Marker of Oxidant Stress In Vivo
Circulation,
June 3, 1997;
95(11):
2492 - 2499.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. J. Kapadia, J. S. Terlato, and A. S. Most
Presence of a Critical Coronary Artery Stenosis Does Not Abolish the Protective Effect of Ischemic Preconditioning
Circulation,
March 4, 1997;
95(5):
1286 - 1292.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Saraste, K. Pulkki, M. Kallajoki, K. Henriksen, M. Parvinen, and L.-M. Voipio-Pulkki
Apoptosis in Human Acute Myocardial Infarction
Circulation,
January 21, 1997;
95(2):
320 - 323.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Ambrosio, S. Betocchi, L. Pace, M. A. Losi, P. Perrone-Filardi, A. Soricelli, F. Piscione, J. Taube, F. Squame, M. Salvatore, et al.
Prolonged Impairment of Regional Contractile Function After Resolution of Exercise-Induced Angina: Evidence of Myocardial Stunning in Patients With Coronary Artery Disease
Circulation,
November 15, 1996;
94(10):
2455 - 2464.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. H. Chen
The Scientific Basis for Hypocalcemic Cardioplegia and Reperfusion in Cardiac Surgery
Ann. Thorac. Surg.,
September 1, 1996;
62(3):
910 - 914.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. L. Schaer, L. J. Spaccavento, K. F. Browne, K. A. Krueger, D. Krichbaum, J. M. Phelan, W. O. Fletcher, C. L. Grines, S. Edwards, M. K. Jolly, et al.
Beneficial Effects of RheothRx Injection in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Circulation,
August 1, 1996;
94(3):
298 - 307.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Wan, A. Marchant, J.-M. DeSmet, M. Antoine, H. Zhang, J.-L. Vachiery, M. Goldman, J.-L. Vincent, and J.-L. LeClerc
HUMAN CYTOKINE RESPONSES TO CARDIAC TRANSPLANTATION AND CORONARY ARTERY BYPASS GRAFTING
J. Thorac. Cardiovasc. Surg.,
February 1, 1996;
111(2):
469 - 477.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. M. Antman
Magnesium in Acute MI : Timing Is Critical
Circulation,
November 1, 1995;
92(9):
2367 - 2372.
[Full Text]
|
 |
|

|
 |

|
 |
 
F.-J. Neumann, I. Ott, M. Gawaz, G. Richardt, H. Holzapfel, M. Jochum, and A. Schomig
Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial Infarction
Circulation,
August 15, 1995;
92(4):
748 - 755.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Ohnishi, M. C. Butterfield, J. E. Saffitz, B. E. Sobel, P. B. Corr, and J. A. Goldstein
Deleterious Effects of a Systemic Lytic State on Reperfused Myocardium : Minimization of Reperfusion Injury and Enhanced Recovery of Myocardial Function by Direct Angioplasty
Circulation,
August 1, 1995;
92(3):
500 - 510.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Zahger, J. Yano, A. Chaux, M. C. Fishbein, and W. Ganz
Absence of Lethal Reperfusion Injury After 3 Hours of Reperfusion : A Study in a Single-Canine-Heart Model of Ischemia-Reperfusion
Circulation,
June 15, 1995;
91(12):
2989 - 2994.
[Abstract]
[Full Text]
|
 |
|
|